-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.O1.6 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities I Clinically Relevant Abstract

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, Biological therapies, adult, Acute Myeloid Malignancies, AML, MDS, clinical trials, Bone Marrow Failure Syndromes, Clinical Practice (Health Services and Quality), Aplastic Anemia, Clinical Research, Hemoglobinopathies, Chronic Myeloid Malignancies, pediatric, Diseases, Therapies, Lymphoid Malignancies, Adverse Events, registries, Myeloid Malignancies, Study Population, Human, Transplantation
Monday, December 12, 2022: 4:30 PM-6:00 PM
260-262 (Ernest N. Morial Convention Center)
Moderators:
Joseph Maakaron, MD, University of Minnesota and Filippo Milano, MD, Fred Hutchinson Cancer Center
Disclosures:
Maakaron: ADC Therapeutics: Research Funding; Gilead: Research Funding; CRISPR Therapeutics: Research Funding; Precision Biosciences: Research Funding.
4:30 PM

Raynier Devillier1,2,3*, Edouard Forcade, MD, PhD4, Jacques-Olivier Bay, MD, PhD5,6, Anne Huynh7*, Anna Berceanu, MD8*, Regis Peffault De Latour9*, Claude-Eric Bulabois, MD10*, Mohamad Mohty, MD PhD11, Michael Loschi, MD, PhD12*, Emmanuelle Tavernier, MD13*, Micha Srour14*, Patrice Chevallier, MD15, Amandine Charbonnier, MD16*, Aline Schmidt17* and Didier Blaise, MD, PhD18

1Hematology Department, Institut Paoli-Calmettes, Marseille, France
2Aix Marseille University, Medicine Faculty, Marseille, France
3CRCM / INSERM U1068, Marseille, France
4Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France
5University of Auvergne, EA7453, CIC501, Clermont-Ferrand, France
6CHU de Clermont-Ferrand, Site Estaing, Service de thérapie cellulaire et d'hématologie clinique adulte, Clermont-Ferrand, France
7Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
8Clinical Hematology, Besançon University Hospital, Besançon, France
9Hematology and Transplantation Unit, Hôpital Saint Louis, AP-HP, Paris, France
10Service d'Hématologie, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
11EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France
12Hematology department, CHU de Nice, Universite Cote d'Azur, Nice, France
13Hematology Department, Oncology institute of Loire, Saint Priest en Jarez, France
14Hematology, University hospital of Lille, Lille, FRA
15Hematology Department, Nantes University Hospital, Nantes, France
16Service d’Hématologie Clinique et Thérapie cellulaire, Centre Hospitalier Universitaire d’Amiens, Amiens, France
17Clinical Hematology, Angers University Hospital, Angers, France
18Institut Paoli-Calmettes, Aix Marseille Univ, CNRS, INSERM, CRCM, Marseille, France

4:45 PM

Adetola A. Kassim, MBBS, MS1,2, Karina Wilkerson, MSN, NP3*, Josu de la Fuente, PhD4,5, Adriana Seber, MD, MS6,7,8, Roseane V Gouveia9*, Carmem Bonfim, MD, PhD10,11,12*, Belinda Pinto Simões, MD, PhD13,14,15*, Erfan Nur, MD, PhD16, Biljana N. Horn, MD17,18,19, Michael Eckrich, MD, MPH20, Rabi Hanna, MD21,22, Nathalie Dhedin, MD23,24*, Fahed Almhareb, MBBS, FACP25, Mahmoud Aljurf, MD25, Hemalatha G. Rangarajan, MD26, Katie S. Gatwood, PharmD27*, James P Connelly, MD28*, Mohsen Alzahrani, MD29,30,31*, Ali Alahmari, MD25*, Mark Rodeghier, PhD32* and Michael R. DeBaun, MD, MPH33

1Vanderbilt-Meharry Sickle Cell Disease Center of Excellence, Vanderbilt University School of Medicine, Nashville, TN
2Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
3Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
4Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
5Imperial College Healthcare NHS Trust, St Mary's Hospital, London, United Kingdom
6Pediatric Hematopoietic Stem Cell Transplantation, Pediatric Oncology Institute - Graacc - Unifesp, Sao Paulo, Brazil
7Hospital Samaritano, Sao Paulo, SP, Brazil
8Hospital Samaritano, São Paulo, Brazil
9Hospital Sao Camilo Pompeia, Pediatric Oncology and Hematopoietic Cell Transplantation, São Paulo, Brazil
10Bone Marrow Transplantation unit, Federal University of Parana, Curitiba, PR, Brazil
11Instituto de Pesquisa Pele Pequeno Príncipe/Hospital Infantil Pequeno Principe, Curitiba, Brazil
12Pediatric Blood and Marrow Transplantation Program, Federal University of Parana, Curitiba, PR, Brazil
13Center for Cell-Based Therapy, Hemotherapy Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
14Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, Brazil
15Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil., Ribeirão Preto, Brazil
16Department of Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands
17UF Health Shands Children’s Hospital, Gainesville, FL
18UCSF, Gainesville, FL
19Department of Pediatrics, University of Florida, Gainesville, FL
20Levine Children's Hospital At Carolinas Medical Center, Charlotte, NC
21Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
22Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Cleveland Clinic Foundation, Cleveland, OH
23St-Louis Hospital, APHP, Paris Cedex 10, FRA
24St-Louis Hospital, APHP, Adolescents and Young Adults Hematology Department, Paris, France
25Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
26Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Childrens Hospital, Columbus, OH
27Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN
28Department of Pediatrics, Division of Pediatric Hematology Oncology, Vanderbilt University Medical Center, Nashville, TN
29King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
30College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
31Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia
32Statistical Consultant, Rodeghier Consultants, Chicago, IL
33Department of Pediatrics, Division of Hematology & Oncology, Vanderbilt University School of Medicine, Nashville, TN

5:00 PM

Rachel M Gilmore, PharmD1*, Karin M Abernathy, PharmD2*, Kendall C Shultes, PharmD3*, Dwight D Eplin, PharmD3*, Lindsay Orton, PharmD4*, Adetola A. Kassim, MBBS, MS5, Bipin N. Savani, MD6, Salyka M. Sengsayadeth, MD6,7*, Brian G. Engelhardt, MD6,8,9, Wichai Chinratanalab, MD6, TaeKon Kim, MD10,11, Bhagirathbhai Dholaria, MBBS6,12,13,14,15, Reena Jayani, MD4,6, Leena Choi, PhD16*, Elizabeth McNeer, MS16* and Katie S. Gatwood, PharmD17*

1Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN
2Sarah Cannon Cancer Center, Nashville, TN
3VA Tennessee Valley Healthcare System, Nashville, TN
4Vanderbilt University Medical Center, Nashville, TN
5Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN
6Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
7Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
8Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
9Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Brentwood, TN
10Division of hematology/oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
11Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
12Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
13Vanderbilt University Medical Center and Vanderbilt- Ingram Cancer Center, Nashville, TN
14Division of Hematology/Oncology, Department of Medicine, Vanderbilt School of Medicine, Nashville, TN
15Vanderbilt University Medical center, Nashville, TN, USA, Nashville, TN
16Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
17Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN

5:15 PM

Alexandros Spyridonidis1*, Myriam Labopin, MD2*, Tobias Gedde-Dahl, MD3*, Arnold Ganser, MD4*, Matthias Stelljes, MD5*, Charles Craddock6,7, Eva Maria Wagner, MD8, Jurjen Versluis, MD, PhD9*, Thomas Schroeder10, Igor Wolfgang Blau, MD11,12*, Gerald Wulf, MD13*, Peter Dreger, MD14*, Gitte Olesen15*, Henrik Sengeloev16*, Nicolaus Kröger, MD17*, Victoria Potter, MBBS, BSc, FRACP, FRCPA18*, Edouard Forcade, MD, PhD19, Jakob Passweg, MD20*, Regis Peffault De Latour21*, Johan Maertens22*, Keith Wilson, FRCPath, MRCP, MBBS23*, Jean-Henri Bourhis, MD24*, Bipin Savani, MD25, Fabio Ciceri, MD26*, Arnon Nagler, MD27 and Mohamad Mohty, MD PhD28

1Hematology Stem Cell Transplant Unit, School of Medicine, University of Patras, PATRA, Greece
2Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
3Rikshospitalet, Clinic for Cancer Medicine, Hematology Dept., Section for Stem Cell Transplantation, Oslo University Hospital, Oslo, Norway
4Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany
5University Hospital of Muenster, Muenster, Germany
6Department of Haematology, University Hospital Birmingham NHS Trust, Queen Elizabeth Medical Centre, Birmingham, ENG, United Kingdom
7Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
8Department of Haematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany
9Erasmus University Medical Center Cancer Institute, Rotterdam, Rotterdam, Netherlands
10Dept. of Bone Marrow Transplantation, University Hospital Essen, Essen, Germany
11Department of BMT, Clinic of Hematology, Oncology and Tumorimmunology, University Medicine Berlin, Berlin, Germany
12Dept. Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Berlin, Germany
13University Medicine Göttingen, Hematology and Medical Oncology, Goettingen, Germany
14Department of Medicine V, University of Heidelberg, Heidelberg, Baden-Wuerttemberg, Germany
15Aarhus University Hospital, Aarhus, DNK
16Rigshospitalet, Copenhagen, Denmark
17University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
18King's College Hospital NHS Foundation Trust, London, United Kingdom
19Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France
20University Hospital, Hematology, Basel, Switzerland, Basel, Switzerland
21Assistance Publique–Hôpitaux de Paris, Saint-Louis Hospital, Université Paris Cité, Paris, France
22University Hospital Gasthuisberg, Leuven, Belgium
23University Hospital of Wales, Cardiff, United Kingdom
24BMT Service, Department of Hematology, Institut Gustave Roussy, Villejuif, France
25Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
26Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
27Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
28Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France, Paris, France

5:30 PM

Li Xuan1*, Min Dai1*, Erlie Jiang, PhD2*, Yu Wang3*, Fen Huang1*, Zhiping Fan1*, Na Xu1*, Danian Nie4*, Xinquan Liang5*, Hong Chen6*, Jieyu Ye1*, Pengcheng Shi1*, Hui Liu1*, Hua Jin1*, Ren Lin1*, Chenhua Yan3*, Yu Zhang1*, Jing Sun1*, Mingzhe Han2* and Qifa Liu, MD1

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
3Institute of Hematology, Peking University People’s Hospital, Beijing, China
4Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
5Department of Hematology, First People’s Hospital of Chenzhou, Chenzhou, China
6Department of Hematology, Southern Medical University Nanfang Hospital, Guangzhou, China

5:45 PM

Kimimori Kamijo, MD1*, Yoshimitsu Shimomura, MD2,3*, Sung-Won Kim, MD, PhD4*, Takahide Ara, M.D., Ph.D.5*, Jun Ishikawa6*, Tetsuya Eto, MD, PhD7*, Nobuhiro Hiramoto, MD8*, Ishikazu Mizuno, MD9*, Shigeru Kusumoto, MD, PhD10, Yasunori Ueda11, Ken-ichi Matsuoka, MD, PhD12, Makoto Onizuka, MD, PhD13, Takahiro Fukuda4*, Yoshiko Atsuta14,15* and Eisei Kondo16*

1Rinku General Medical Center, Izumisano, Japan
2Department of Haematology, Kobe City Medical Center General Hospital, Kobe, Japan
3Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan
4Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
5Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
6Osaka International Cancer Institute, Osaka, Japan
7Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
8Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan
9Department of Hematology, Hyogo Cancer Center, Akashi, Japan
10Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
11Department of Haematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan
12Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
13Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
14Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
15Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
16Kawasaki Medical School, Kurashiki, OKA, Japan

*signifies non-member of ASH